Pharmacokinetic Modelling of 5-FU Production from Capecitabine—A Population Study in 40 Adult Patients with Metastatic Cancer

By Urien Saik   Rezaí Keyvan   Lokiec François  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 32, Iss. 5-6, 2005-12 ,pp. : 817-833

Springer Publishing Company

Access to resources Recommend Favorite

Population Pharmacokinetic Analysis of 5-FU and 5-FDHU in Colorectal Cancer Patients: Search for Biomarkers Associated with Gastro-Intestinal Toxicity

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 15, 2012-08 ,pp. : 1713-1719

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of Subchronic Toxicity Data Using the Benchmark Dose Approach

By Gephart L.A.   Salminen W.F.   Nicolich M.J.   Pelekis M.  

Regulatory Toxicology and Pharmacology, Vol. 33, Iss. 1, 2001-02 ,pp. : 37-59

Academic Press

Access to resources Recommend Favorite

GALNT14 SNP as a potential predictor of response to combination chemotherapy using 5-FU, mitoxantrone and cisplatin in advanced HCC

By Liang Kung-Hao   Lin Chen-Chun   Yeh Chau-Ting  

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 1061-1073

Future Medicine

Access to resources Recommend Favorite

Capecitabine: Cerebellar toxicity in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1339, 2011-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite